Capital Performance Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Sell |
2,252
-437
| -16% | -$341K | 0.34% | 46 |
|
|
2025
Q1 | $2.22M | Buy |
2,689
+2,100
| +357% | +$1.73M | 0.49% | 35 |
|
|
2024
Q4 | $455K | Sell |
589
-171
| -23% | -$132K | 0.15% | 62 |
|
|
2024
Q3 | $673K | Buy |
760
+300
| +65% | +$266K | 0.2% | 42 |
|
|
2024
Q2 | $417K | Buy |
460
+36
| +8% | +$32.6K | 0.16% | 53 |
|
|
2024
Q1 | $330K | Buy |
424
+51
| +14% | +$39.7K | 0.13% | 56 |
|
|
2023
Q4 | $217K | Buy |
+373
| New | +$217K | 0.09% | 66 |
|